Enlivex Stock Hits Record Low as RAIN Treasury Draws Scrutiny
Share:
Enlivex shares plunged to an all-time low of $0.42, down 94% over five years and 30% year-to-date, after the biotech announced a November 2025 pivot to a prediction markets RAIN token treasury. The company raised over $200 million via a private placement at $1 per share funded in dollars and USDT and began accumulating RAIN on Arbitrum, but wallet addresses were linked in May to accounts tied to Moshe Hogeg, raising security, regulatory and adoption risks for the crypto treasury and governance token.
Predictions Markets
See what traders are focused on
- Enlivex shares hit an all-time low of $0.42, down 94% over five years on Nasdaq.
- Enlivex pivoted to a RAIN token treasury in November 2025 and raised over $200M.
- ZachXBT linked RAIN wallet addresses to accounts tied to Moshe Hogeg in May.
Every retail investor who has ever bought shares of Enlivex on the Nasdaq has now lost money. The stock hit an all-time low of $0.42, falling 94% over five years and 30% decline this year alone.
From Biotech To Crypto Treasury
Enlivex spent years developing clinical therapeutics before abruptly reinventing itself in November 2025 as what it called the world’s first prediction markets digital asset treasury strategy. The company raised over $200 million through a private placement at $1 per share, funded in dollars and USDT, and began accumulating RAIN, a governance token on an Arbitrum-based protocol that it compared to Uniswap…
Read The Full Article Enlivex Stock Hits Record Low as RAIN Treasury Draws Scrutiny On Coin Edition.
Read More
Bitcoin Hits Record Oversold Level Against Gold, Echoing a 660% Rally
